AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹14,670 Cr | ₹12,480 Cr | ₹11,573 Cr | ₹9,966 Cr | ₹9,888 Cr |
What is the latest Net Current Assets ratio of AUROBINDO PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹14,670 Cr |
| Mar2025 | ₹12,480 Cr |
| Mar2024 | ₹11,573 Cr |
| Mar2023 | ₹9,966 Cr |
| Mar2022 | ₹9,888 Cr |
How is Net Current Assets of AUROBINDO PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹14,670 Cr | 17.54 | |
| Mar2025 | ₹12,480 Cr | 7.84 | |
| Mar2024 | ₹11,573 Cr | 16.12 | |
| Mar2023 | ₹9,966 Cr | 0.79 | |
| Mar2022 | ₹9,888 Cr | - | |
Compare Net Current Assets of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹95,573.9 Cr | 4.4% | 4.7% | 39.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 4.4% |
4.7% |
39.3% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses